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ABSTRACT   
Medical implants have undoubtedly made an indelible mark on our world during the last century. More 
than 100 million humans carry at least one major internal medical device. The prosthesis industry has 
topped 50 billion US$ in annual sales, with approximately 150 universities throughout the world proposing 
an undergraduate program in bioengineering or biomedical engineering. Despite that, however, most 
medical devices have been constructed using a significantly restricted number of conventional metallic, 
ceramic, polymeric, and composite biomaterials. In this study, recent developments of metallic implants are 
summarized for biomedical applications. To do this, first desired properties for biomaterials are defined. 
Then, types of metallic biomaterials are classified as stainless steel, Mg, Co, Ti, nobble and biodegradable 
ones. After that, surface modifications are defined for corrugation, topographies and chemical modification. 
Finally, future perspective is outlined for the sake of development new materials as well as production 
point of view.  
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1. Introduction 
A biomedical implant is defined as an artificial organ designed to restore the functionality of a damaged 
natural organ or body tissue. This requires several requirements that must be met before the material used for 
artificial organs or artificial organ construction can be evaluated for application. The main requirement of 
artificial organ or tissue substitution is that it acts as a functional substitute for the original body part. 
Additional requirements include biocompatibility or biodegradability of the material used in the artificial 
organ, so that the surrounding tissue accommodates without any immune rejection response or inflammatory 
reaction. 
Metals, ceramics, polymers and natural materials are used in biomedical implants. The need to avoid toxic 
substances rarely uses aluminum or its alloys, while plain steel corrodes too fast to use on the body. High 
quality metal titanium, vanadium and chromium alloys are used in orthopedic prostheses (artificial joints) or 
for fixing plates to fix fractures. Engineering ceramics such as aluminum oxide have been found to provide a 
hard, low-friction surface that is also suitable for orthopedic prostheses. In many cases, hard aluminum oxide 
is paired with Ultra High Molecular Weight Polyethylene to produce a very durable container for the hip joint 
prosthesis and a softer yet wear-resistant polymer to produce a ball joint. 
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Composite materials attracted attention as biomedical materials. Carbon fiber braids were examined as 
reinforcing materials for the bodies of orthopedic implants. Surface coatings have been developed to coat a 
metal into a more acceptable coating by the human body. Metals in basic form are essentially foreign to the 
human body. When a metal implant is inserted into the tissue, most metals are encapsulated with a thin layer 
in which human cells are almost empty. Adhesion between the metal implant and the surrounding tissue is 
relatively weak. Bones contain hydroxyapatite (a form of calcium phosphate) as a structural matrix. When a 
metal implant is covered with hydroxyapatite, bone cells adhere to the surface of the apatite coating without 
any interference layer. The hydroxyapatite matrix of bone cells then integrates with the hydroxyapatite coating 
and adheres perfectly to the coated implant bone. 
The range of biomedical materials is expanding very quickly; There is a rapidly expanding range of polymer 
materials recommended as biomaterials. Biocomposites, that is, composite materials intended for use as 
biomaterials also contribute to the potential material range. Composite materials develop beyond the relatively 
simple structure of two, perhaps three, materials for systems with a nanometer scale engineering structure. 
Vacuum-based surface coating technologies such as Physical Vapor Deposition are used to form regular 
polysaccharide molecule sequences on a supporting polymer membrane. The purpose of this composite 
biomedical material is to adsorb selective proteins and reject other proteins. This material can be attached to 
the electrodes to form a sensor for individual proteins [1]. 
The basic function of biomedical material varies. The original form of the biomedical implant was a separate 
material, such as a plate that connects broken bones. Although this type of implant is likely to be in use in the 
foreseeable future, a new form of implant is rapidly emerging. Highly porous implants, often referred to as 
'scaffolds', act as matrices to support cell growth or regrowth when the original tissue is defective. The vital 
material properties for these 'scaffolds' are flexibility and permeability, so that the cells inside are not 
protected from mechanical stresses applied to tissues and are not removed from the natural flow of cellular 
nutrients. It has been found that mechanical stress is required for cell growth in tissues such as arterial and 
vein walls. If the scaffold is made of natural material, it can even function as a food for cells. Effectively 
designed scaffolds can provide tissue regeneration in orthopedic joints, intestines and artery walls [2]. 
Regenerated tissue is more acceptable for the patient than having to live with an artificial material implant that 
is completely different from the tissues. This article briefly reviews various metal biomaterials, including 
stainless steel, Mg, Co and Ti based alloys, as well as biodegradable alloys that have the potential to face the 
challenges of biomedical engineering. In addition, the surface modifications of the implants are outlined and 
the future perspective is reflected for possible improvements. 
 
2. Preferred properties of biomaterials 
A biomaterial must meet the following criteria: 
Mechanical properties: By matching the flexibility module of biomaterials with bone ranging from 4 to 30 
GPa, stress protection can be avoided [3]. In addition, the material must have a low modulus combined with 
high strength to prolong the service life of the implant and prevent loosening, so revision surgery is not 
required. 
Biocompatibility: The material developed should be compatible with living systems and should not cause 
bodily harm, including all the negative effects of a substance on the components of the biological substance 
(bone, extracellular tissues and the ionic composition of the plasma) [4]. 
High abrasion resistance: The material should have high abrasion resistance and show a low coefficient of 
friction when sliding into body tissues. Increased friction coefficient or decreased wear resistance may cause 
the implant to relax [5]. In addition, wear now can cause inflammation that damages the bone that supports the 
implant. 
High corrosion resistance: An implant made of a biomaterial with low corrosion resistance can release metal 
ions in the body, causing toxic reactions [6]. 
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Osseointegration: Osseointegration was first described as "a direct structural and functional link between the 
surface of an organized, live bone and a load-bearing implant" [7]. Surface roughness, chemistry and 
topography play an important role in good osseointegration [8]. Implant relaxation results from the integration 
of the implant surface into the adjacent bone [9]. Few researchers say that osseointegration is undesirable 
because of the risk of not being able to remove the implant after use [10]. However, a few have also shown 
that the implant can be safely removed [10]. Therefore, osseointegration is a desirable feature in some 
applications, such as implants, for a biomaterial that is required to ensure the proper integration of the implant 
with bone and other tissues [11]. 
Non-toxic: The material should be neither genotoxic (can alter the DNA of the genome) nor cytotoxic 
(damaging cells). 
Long fatigue life: The material should show high resistance to fatigue and failure to prevent implant failure 
and stress protection from fatigue fracture. Implants have been reported to fail with fatigue in hip prostheses 
[12]. 
3. Types of biomaterials  
The materials used in the construction of biomedical devices (orthopedic, dental, bone cements, etc.) can be 
classified as metallic materials, ceramics, polymers and composites. Metallic materials in these four categories 
are widely used due to their high strength, toughness and good biocompatibility, despite some deficiencies 
such as release of metallic ions and wear residues. Therefore, only metallic materials will be summarized 
below as biomaterial. 
3.1. Metallic alloys  
The high reliability of metallic biomaterials in terms of mechanical performance has resulted in the use of 
"mainly for the production of medical devices for the replacement of hard tissues such as arterial hip joints, 
bone plates and dental implants" [13]. Various properties and properties of a wide variety of materials and 
alloys have been investigated in the medical field [14]. Different alloy systems have been developed for use in 
the medical field, including stainless steels, Co alloys and Ti alloys. Table 1-3 summarizes the chemical 
composition of alloys registered in the ASTM Standard and developed for biomedical applications [15]. A 
brief description of each material is given below.  
 
Table 1. Titanium-based biomedical alloys [16] 
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Table 2. Chemical compositions of stainless steels-based biomedical alloys (ASTM) [16] 
 
 
Table 3. Chemical compositions of Co alloys registered in ASTM standard for biomedical applications [16] 
 
 
3.1.1. Stainless steel  
In the 1920s, 316L stainless steel became a candidate implant material with good mechanical properties and 
many applications such as healthcare products. Now studies have revealed that 70% of Orthinox stainless steel 
is used for hip substitutions in the USA [16]. It is an iron-based alloy containing 11-30% by weight of 
chromium and unspecified nickel [17]. Stainless steel metals are basically divided into four main categories: 
Martensitic (BCT-hardest crystalline structure), ferrite (BCC crystalline structure), austenite (FCC crystalline 
structure) and duplex (austenitic (FCC) plusferrite (BCC) phase). The three stainless steel categories confirm 
the importance in medical equipment and are widely used for implantation applications. The utility of 
stainless steel depends on (a) availability (b) low cost, (c) excellent production (d) good biocompatibility (e) 
toughness, and (f) excellent corrosion resistance [17]. However, the main limitation of stainless steel is 
associated with crack and abrasion corrosion due to damage to the defensive chrome oxide surface film [18]. 
When proper surface treatment is not performed, it is often seen that stainless steel causes unwanted biological 
reactions in the human body [19]. Unlike surface treatment of metals such as titanium, aluminum, gold, 
silicon-based materials and polymers, research on surface modification of stainless steel is less [20]. It is 
therefore important to analyze the surface moderation of stainless steel to achieve improved surface 
engineering through chemical stability, mechanical properties, corrosion resistance, blood interface and 
longevity [21]. Liu et al. [22] used the water-based sol-gel technique to deposit thin hydroxyapatite film on a 
coarse 316L stainless steel sample. The presence of microcracks has been shown to reduce the interfacial bond 
strength of the film, however, it was observed that the adhesion of this coating was 40% more apparent than 
plasma spray coatings. 
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Table 4. Categorizations of stainless steels medical alloys [23] 
 
 
3.1.2. Mg-based alloys  
Sir Humphry Davy discovered the element magnesium in 1808 and then began researching a biodegradable, 
biodegradable magnesium implant for biomedical purposes. In the late nineteenth century, magnesium wires 
and implants began to be used in clinical applications such as cardiovascular, drainage, musculoskeletal, and 
general surgery [24]. The density and modulus of elasticity of magnesium implants and natural bones are 
almost the same compared to other commonly used implants made of stainless steel, cobalt-based alloys and 
titanium alloys. This significantly reduces the stress-protective effect of bone restoration [25]. The need for 
secondary surgery to remove the magnesium implant is inevitable because magnesium is broken down and 
removed from the urine in vivo [26]. It is also known that Mg2 + contaminants support the growth of new 
navicular bone tissue and shorten the cracking time [27]. A related study showed that the human body 
consumes 250-500 mg of magnesium particles per day with physiological functions. The presence of Mg in an 
average of 70 kg of human body is about 20 g; the harmful amount is still uncertain [28]. The advantage of 
magnesium is based on natural properties such as (a) a higher weight-to-weight ratio, (b) good electrical 
thermal conductivity, (c) excellent vibration and damping, (d) higher damping capacity and (e) an efficiency 
of electromagnetic shielding. [29]. 
The main limitation when using magnesium components as implants is the presence of an unprotected or 
faulty oxide film on the sample surface, which causes increased component corrosion [30]. Another problem 
is the growth of uncontrolled hydrogen bubbles during corrosion; If the formation of hydrogen gas is too 
rapid, an obstruction to the blood flow can lead to swelling [28]. There are two possible approaches to 
increasing the corrosion resistance of Mg and Mg amalgams: (i) change in composition and microstructure 
containing the grain size [31] and (ii) surface treatment or structural coatings [32]. 
To increase the corrosion resistance and in vitro bioactivity of magnesium alloys, Razavi et al. [33] used the 
microarchoxidation method with an electrophoretic deposition process to develop a nanostructured coating 
made of acermanite and diopside (CaMgSi2O6) on a biodegradable magnesium alloy. To prevent the initial 
breakdown of magnesium, Chen et al. [34] proposed a strontium phosphate (SrP) conversion coating process. 
The coating solution containing 0.1 M Sr and 0.06 M PO43 is reported to produce a strontium apatite (SrAP) 
surface coating at 80 ° C in a minimal basic environment (MEM) which increases the corrosion resistance of 
the magnesium sample. As a result, the formation of hydrogen gas delayed the toxic effects of magnesium 
implants on the surrounding cells and tissues. 
The performance of the calcium phosphate film on a magnesium alloy was analyzed by an electrochemical 
method [35]. Impact and constant potential techniques were used to coat the magnesium sample, and the 
results showed that the alloy coated with impact potential had better corrosion resistance and three times 
higher polarization resistance than the constant potential coated alloy. 
The Lu team [36] also used the β-tricalcium phosphate (CaP P) coating by chemical reaction of Mg in 
simulated Hank solution. The Ca-P coating has been found to improve the bioactivity, rate of deterioration 
and corrosion resistance of the sample. In the following research study, they changed the Ca-P coating by 
introducing strontium (Ca-Sr-P) and left the electrolyte solution in a pure magnesium sample [37]. (Ca-Sr-P) 
mixture gave a very smooth, thin and improved microstructure layer on the surface. However, it also helped 
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protect the magnesium substrate from degradation. Nanostructured self-assembled monolayers (SAM) for 
surface modification of Mg and its alloys were developed by Mahapatro et al. [38] They conclude that SAMs 
are a promising technique to change the surface of biodegradable Mg substrates and to improve their 
performance and response to biological interfaces. 
3.1.3. Co-based alloys  
The wear resistance of Co alloys is higher than the wear resistance of Ti alloys and stainless steel alloys [15]. 
In artificial hip joints, the head of the joint is subject to wear. Thus, hip joints are made of Co alloys, such as 
Co-Cr-Mo alloys that exhibit high strength and ductility. Carbide dispersed in Co alloys has been reported to 
increase the wear resistance of these alloys [13]. In addition, the conversion of the metastable γ phase to the 
ens martensitic phase (through a deformational transformation) has been found to increase the wear resistance 
of the Co alloys [13]. Compared to cast Co-Cr alloys, machined Co-Cr alloys can be used for implant devices 
with high strength requirements. However, the Ni content in forged Co-Cr alloys causes allergic reactions 
[15]. Some of the mechanical properties of metallic biomaterials are compared in Table 5. Examples, 
advantages and disadvantages of metallic alloys used in biomedical applications are summarized in Table 6. 
As seen in Table 5, Young's Co-Cr alloys module and 10 times more steel than stainless steel can cause strain. 
However, Young's titanium and alloys module is about 0.5 times higher than that of stainless steel, and 
therefore the risk of stress protection is lower in Titanium and its alloys compared to Co-Cr alloys and 
stainless steel. 
 
Table 5. Evaluation of mechanical properties of bone with metallic biomaterials [39] 
 
Table 6. Evaluation of metallic biomaterials used in the human body [39]. 
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3.1.4. Ti-based alloys  
More than 1000 tons of titanium-based materials and devices are implanted to patients worldwide every year 
[40]. Initial efforts to implant Ti-based biomaterials date back to the 1930s when Ti was seen to be adequately 
accepted by femoral bone tissues in felines, similar to stainless steel and Co-Cr-Mo. The biomedical use of Ti 
is due to the relative lightness of the metal compared to conventional steel and Co-Cr alloys, characterized by 
relevant densities of 4.5, 7.9 and 8.3 g / cm3. Ti is also superior in terms of biocompatibility, biocorrosion 
resistance, specific strength and elastic modulus. 
Depending on their chemical composition, commercially pure Ti is divided into four degrees, where the% by 
weight of inclusions increase from grade I to grade IV and reach a maximum of 0.7%. O (0.18-0.4% by 
weight), N (0.03-0.05% by weight) and Fe (0.20-0.50% by weight) have been shown to significantly affect the 
ductility and strength of Ti. Allotropism in Ti means that the allotropic transformation temperature of 885 ° C 
is defined by a hexagonal sealed α structure of the material under TAT, at higher temperatures Ti takes on a 
body-centered cubic β structure. The addition of Al, Sn, C, O or N has been shown to stabilize the a-structure 
by increasing TAT; however, Mo, Nb, V, Cr and Fe reduce TAT, thus contributing to the β - structure. Unlike 
form Β, a-phase materials exhibit excellent heat and oxidation resistance and weldability (due to single-phase 
microstructure), but less workability and strength. 
 
Figure 1. Inﬂuence of thermomechanical processing on development of various microstructures in  α – β  
titanium alloys [21]. ST (solution treatment) 
 
Commercially pure Ti is an α -type alloy. Hardening via heat treatment is not used for these single- phase 
alloys, as increased strength is generally attributed to the precipitation of one phase in the multi-phase system. 
Using speciﬁc amounts of β - stabilizing elements, a two-phase structure comprising both α and β phases can 
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be attained. The most popular Ti- based biomedical alloy, Ti6Al14V, is comprised of Al (5.5–6.5 %wt) and V 
(3.5–4.5 %wt), and is a good example of a two- phase structure where the  β - phase is dispersed within the  α 
- phase. The precipitation is achieved by means of annealing, followed by rapid cooling (quenching) and 
subsequent thermal ageing. The latter prompts the metastable β -phase to precipitate in a form of small 
particles, with the resultant structure showing improved strength compared to an  α -  β  alloy that has been 
subjected to heat treatment only. In Ti-13V11Cr-3Al alloys, a relatively large concentration of V imparts a 
clearly β - type microstructure and thus annealing can signiﬁcantly increase the strength of the material while 
reducing its ductility. Figure 1 shows the effect of thermomechanical processing on microstructure of Ti 
alloys [8].  
Medical use of Ti-12.5Mo, Ti-8Al-7Nb, Ti-13Nb-13Zr, Ti-29Nb-13Ta4.6Zr and Ti-121Mo-6Zr-2Fe has also 
been proposed [41-43]. The excellent mechanical properties, anti-corrosion ability, cytocompatibility and 
biocompatibility of Ti15Nb4Ta4Zr alloys make them suitable for orthopedic implants [44]. Compared to 
Ti6Al4V, this alloy improved new bone formation and bone mineral density, which is equal to or higher than 
Ti6Al4V [44]. It has been reported that increasing the Nb content, especially by means of an oxidation 
process, increases the wear resistance of the alloy due to the hardness and lubricity of the Nb2O5 layer [45]. 
Since Ti-NbTa-Zr alloys cannot form apatite on their surface under conventional chemical and heat treatment 
processes, another surface modification method is required [46].  
As with other metallic biomaterials, the mechanical properties of Ti and Ti-based alloys vary depending on 
the type and weight% of the alloy impurities and the processing methodology. The elastic modulus of Ti-
based materials at 100 GPa is relatively low compared to steel and Co-Cr alloys, whereas the strength profile 
is similar among these materials [47]. A biomaterial with a lower Young's modulus can transfer stress 
between itself and bone homogeneously; however, as the module approaches a bone, the probability of failure 
will increase under high shear deformation in vivo [48]. Since the fatigue test, which is sufficiently replicated 
in vivo, is complex, it is difficult to predict exactly how the material will behave under stress after 
implantation [49].  
The standardized in vitro fatigue test includes the Ti-6Al-4V alloy used as a standard material for comparing 
the results and tension / compression, bending, torsion, and rotating bending fatigue studies [50]. Compared to 
their specific strengths, Ti-based materials are superior to other implantable metals. For commercially pure Ti, 
tensile strength values of 240 to 550 MPa are expected to be between 170 and 485 MPa, 15 to 24% elongation 
and 25 to 30% reduction in area. The tensile strength of Ti-6Al-4V alloys is about 860 MPa, regardless of 
whether the alloy is poured or poured. Other parameters differ from 758 and 795 MPa yield strengths, a 
minimum elongation of 8 and 10%, and a minimum reduction of 14 and 20% for cast and forged alloys. The 
pure strength of Ti biomaterials, ie against a force that can produce slip errors on a material parallel to the 
direction of the force, is relatively low. 
In addition, Ti materials are susceptible to tribocorrosion in the applications that entail a sliding contact 
between the device components in physiological ﬂuids, such as between the femoral and the tibial or 
acetabular elements of the hip joint replacement implant [42]. Tribocorrosion is inﬂuenced by the electro-
chemical and mechanical conditions of the contact, and generally results in the increased rate of biomaterial 
degradation [41]. Certain Ti alloys, such as Ti-29Nb-13Ta-4.6Zr, have been demonstrated to recover their 
passive surface conﬁgurations under both sliding and fretting contacts [43]. Wear and corrosion resistance of 
martensitic Ti 6Al 4V ELI alloys was signiﬁcantly better compared to Ti-6Al-4V ELI alloys with an  α - β  
microstructure [41]. Other studies have suggested the relationship between the microstructure of the material 
and the rate of its wear is not straightforward [51]. Plasma nitriding of the Ti surfaces has also been shown to 
improve the wear properties of the material through the formation of a hard compound layer of TiN and Ti 2 
N [52]. Plasma assisted chemical vapor deposition of hydrogenated amorphous carbon (a-C:H) onto the 
surface of the Ti-6Al-4V alloy was also suggested as a method to improve corrosion and wear resistance of 
the material [53]. Although beneﬁcial at low applied load, the coatings failed prematurely under higher load.  
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Otherwise, in vivo biocompatibility and corrosion resistance of highly reactive Ti and Ti based alloys results 
from the presence of a robust passive oxide Ti ﬁm on their surface [40]. In general, the corrosion process 
causes a rapid reaction on the surface of all metals, from reactive Ti to noble Au. Under certain environmental 
conditions, for example in the absence of low solubility and defects, such a reaction lm will be characterized 
by strong adhesion to the substrate and protect the underlying bulk material from deterioration. Typically, 
these passive oxide layers are 1 to 5 nm thick, optically transparent, and amorphous in nature. The amorphous 
structure of the layer with the minimum grain boundary and the self-healing feature of ﬁ lm provide low 
sensitivity to corrosion. In the case of Ti, the oxide layer has been shown to contain amorphous and slightly 
crystalline TiO2, Ti2O3 and TiO have also been identified [54]. The passive pl formed on the surface of the 
Ti-6Al-4V alloy was similar in its chemical composition to commercially pure Ti, excluding some Al203 and 
hydroxyl moieties detected in the alloy. Similarly, titanium dioxide formed primarily on the surface of the Ti-
Ni alloy with limited amounts of NiO, metallic Ni and -OH functionality. In contrast, the surface oxide layer 
on the surface of the Ti-Zr alloy has been shown to consist of titanium and zircon oxides in the bulk material, 
affecting the relative concentration ratio of Ti to Zr. Higher Zr concentrations resulted in a thicker, more 
stable protective coating. 
In 2017, Eren et al studied about the “characterization of biomedical TiNbSn alloys produced by PIM” [55]. 
They prepared the alloys by means of PIM method and then they observed that Sn addition had negative effect 
on the sintered density of the alloy when sintering process conducted at lower temperatures (1250-1400 
o
C) 
but it had no or minimum effect when sintering temperature increased to 1550 
o
C (96% TD).   
In 2018, BIMAS-RC group published four papers about the biomedical materials. In the first one, they 
examined “TiNbZr alloys produced via PIM for implant applications” [56]. In this paper they detected by 
XRD and SEM that Zr behaved as a  stabilizer and according to DTA, and it decreased  to  transition 
temperature approximately 30 
o
C, and elastic modulus remained approximately steady between 103 and 110 
GPa (Figure 2). They concluded that TiNbZr alloys can be used as an alternative to known metallic implant 
materials.  
 
Figure 2. Mechanical properties of the produced PIM Ti–Nb–Zr alloys [56] 
 
In the second paper, they worked on the “metallurgical properties and biomimetics HA deposition 
performance of TiNb PIM alloys” [57]. The aim was to investigate the effect of the Nb amount on the 
microstructure, mechanical properties, corrosion behavior and HA formation ability of Ti-Nb alloys in this 
paper and they used XRD, optical and SEM imaging (Figure 3) for microstructural characterization and 
hardness measurements and transverse rupture strength for mechanical properties. They concluded that with 
the increment of Nb content,  phase stability increased in the + phases. Also, they observed that Nb 
content had significant effects on the mechanical properties of the considered alloys, and they observed 
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lowered elastic modulus (100-115 GPa) than that of the titanium (132-140 GPa). Also, they concluded that the 
addition of Nb contributed to the improvement of corrosion resistance and induced to increase of HA 
formation ability.  
 
Figure 3. Surface morphology of the alkali-treated a) Ti, b) Ti-40Nb c) non-treated Ti40Nb. (After soaking in 
SBF for 7 days) [57] 
 
In the third paper, “mechanical properties and electrochemical behavior of porous Ti-Nb biomaterials” were 
reported by the same group [58]. In this study, Ti16Nb alloys containing porosity between 4 to 60 % were 
produced by powder metallurgy using different amount of space holder materials (Figure 4). The specimens 
were sintered at 1200 
o
C for 3 h in a high-level vacuum. The effects of space holder content were investigated. 
It is seen that the addition of 70 vol% space holder materials to the Ti16Nb alloy leads to a decrease in the 
density value from 4.7 g/cm
3
 to 1.9 g/cm
3
. Also, it is observed that by producing Ti16Nb with 70 vol% space 
holder, elastic modulus decreased from 96 GPa to 15 GPa (Figure 5).  
 
Figure 4. Densities of the samples with different space holder content [58] 
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Figure 5. Compressive stress-strain curves of the porous Ti-16Nb alloy with addition of different amounts of 
NH4HCO3 [58] 
In their last article published in 2018, they worked on "powder metallurgy processing of TiNb-based 
biomedical alloys" [59]. They reported that Sn content (2% and 4% by weight) was added to Ti16NbXSn 
sintered alloys consisting of alpha + beta phases. Hardness and Young's modulus of alloys measured by 
nanoindentation technique. These results show that there is a relationship between mechanical properties and 
Nb-Sn content. It was concluded that adding Nb to cp-Ti caused a decrease in Young's modulus.  
3.1.5. Nobble alloys  
As a result of high durability, stability and excellent corrosion resistance, noble materials and their alloys are 
widely used in restorative dentistry [60,61]. Gold fillings can be produced by casting or mallet with Au alloys 
preferred to pure Au for the casting method. The mechanical performance of Au is lower compared to alloy-
based materials, and foreign materials such as Cu and Pt (<4%) are known to strengthen Au-based alloys. 
However, a high concentration of noble material (> 75%) provides their anti-corrosion performance. If the Au 
level exceeds 83%, the alloy becomes too soft to use in stress-bearing applications such as cups and crowns. 
Pure gold foil is used for hammer restorations where soft layers are installed in the cavity and are combined 
with thermal diffusion of atoms between layers under applied pressure. Elemental Ag is introduced into the 
alloy to improve the color of the product obtained. Higher Pt concentrations (> 4%) have been shown to 
increase the melting point of the alloy, so small amounts of Zn are added to reduce the melting point while 
making the process more complex. The surfaces of Au alloys such as Ag-Cu-Au, Pd-Ag-In-Sn and Ag-Pd-Cu-
Au are encapsulated by Cu and Ag oxides [62]. There were no significant differences in the mechanical yield 
strength between Au-Pd, Pd-Ag, Pd-Ag-Au and Au-Ag-Pd alloys; however, their percent elongation varied 
greatly with the Pd-Ag and Pd-Ag-Au alloys characterized by the highest elongation values [63]. Silver-based 
amalgam is a mercury-containing alloy that is widely used as dental coating material. The dental benefit is due 
to its unique feature for the basic Hg to remain in a liquid phase at room temperature and to produce a plastic 
material that can be easily deformed by reacting with other metals such as Ag and Sn. The use of amalgam is 
preferred over composite large and complex restorations. There are margins in dentin or cement where 
isolation is difficult [64]. In practice, the dry Ag-Sn alloy is mixed with Hg, resulting in the reaction: Ag 3 Sn 
+ Hg ↔ Ag 3 Sn + Ag 2 Hg 3 + Sn 7 Hg. Typical dry alloys consist of more than 65% by weight Ag, less 
than 29% by weight Sn, less than 6% by weight Cu, less than 2% by weight An and less than 3% by weight 
Hg. Plasticity makes it easy to pack the alloy into the dental cavity and then hardens over time. Generally, the 
alloy is expected to reach 2% of its final strength after 60 minutes and almost all of its final strength after 24 
hours of curing. Once completely hardened, the alloy should contain 45 to 55% Hg, 35 to 45% Ag and 15% 
Sn. Tin oxide forms the protective oxide layer on the surface of the material. 
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Dental amalgams have been used for more than 150 years for dental restoration and minimum technological 
requirements for amalgam setup, compared to gold or composite dental materials, due to their malleability, 
durability and affordability [65]. However, there has been much debate about the potential toxicity of these 
substances in vivo. Indeed, even at minute levels, Hg0 is thought to be neurotoxic and nephrotoxic [66]. It is 
therefore possible that Hg0 may leak from amalgam, thereby exposing the patient's body to increased mercury 
burden [67]. Over the years, amalgams have been claimed to contribute to a number of diseases, from multiple 
sclerosis to chronic fatigue, Alzheimer's or Parkinson's disease [68]. However, only a few relevant 
epidemiological studies have been conducted, and even then, data from dental exposure has been compared to 
occupational hazardous mercury exposures. Full-scale clinical trials of the population with amalgam exposure 
are complicated by inadequate longitudinal exposure assessment and negative mixing because higher 
socioeconomic groups will have access to restorative dental care. Some recent clinical studies have found that 
neurobehavioral and neuropsychological performance does not differ significantly between children with and 
without amalgam obstruction [69]. All studies have reported increased urinary total mercury levels, higher 
mean urinary albumin concentration and increased micro-albuminuria in amalgam patients.  
3.1.6. Biodegradable alloys  
Biodegradable metals such as magnesium are particularly promising in applications that promote tissue 
regeneration and healing, especially where load bearing function is required [70]. Magnesium is highly 
biocompatible and nontoxic, Mg ions are essential for human metabolism [71]. Highly suitable for producing 
fully absorbable intravascular stents for the treatment of arterial disease minimizes the risk of chronic 
inflammation and late thrombosis associated with permanent metallic stent implantation. Mg and its alloys for 
osteosynthesis offer high primary stability, high tensile strength and fracture resistance.  
 
Figure 6. Stability of Mg coating deposited by means of physical vapor deposition onto silicon substrate and 
tested under in vitro and in vivo conditions. SEM images of Mg coating consisted of micro grains before (a) 
and after exposure to cell culture (b) and (c). The Mg grains can still be seen after 12 h in the media, a 
promising result considering most Mg alloys corrode after 1 h; (d) SEM images of Mg coating implanted 
subcutaneously in mouse, showed the coating to be well preserved and intact after the in vivo conditions, with 
the thickness of the ﬁbrous capsule in the same range as for titanium control samples suggesting good 
biocompatibility of the Mg grains [72]   
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It is also lightweight, has a density of 1.74 g / cm
3
, which is 1.6 and 4.5 times less intense than aluminum and 
steel, respectively [25]. The specific gravity and elastic modulus of Mg is very close to the human cortical 
bone and reduces anti-stress effects on bone tissue associated with implant integration. In addition, Mg 
bivalent ions play a close role in the formation of biological apatites, thereby determining the extent of bone 
fragility, bone healing and regeneration [24].  
In spite of its favorable mechanical and biological properties, the clinical applications of Mg are limited by its 
rapid corrosion rate in vivo (Fig. 6), especially in a physiological environment with pH values between 7.4 
and 7.6 and biological ﬂuid being present with chloride ions at levels of 150 mmol/L. Such rapid degradation 
may lead to the release of large amounts of Mg
2+
, localized hydrogen gas (H2) accumulation and alkalization, 
and to an untimely loss of mechanical strength of the implanted material [24]. For instance, intravascular 
ultrasound imaging of absorbable Mg stents in human coronary arteries indicated the loss of the radial force 
and consequent early recoil as a main contributor for restenosis at 4 months [72]. Thus, to meet clinical 
requirements, precise understanding of degradation kinetics and control over in vivo degradation of implants 
based on biodegradable metals and alloys are essential, especially at the early stages of implantation where 
degradation may be most pronounced.  
It is important to understand that the environment greatly affects the biodegradation behavior of the 
absorbable material. The biological environment directly affects the properties and behavior of the implant 
material through different physico-chemical parameters (eg PH, ion concentrations, oxygen). Simultaneously, 
as an inserted foreign body, the implant evokes an immunological response and affects the surrounding tissues 
due to direct and close contact. For example, the Mg alloy (AZ31) screws implanted in a sheep hip bone 
differed in biodegradation, corrosion morphology and dynamics; screw threads in the bone, upper muscle / 
connective tissue [73]. Similarly, Mg wires have been shown to undergo extensive biocorrosion when placed 
in the rat arterial wall, whereas for Mg wires exposed to blood in the arterial lumen for 3 weeks, very little 
corrosion has been observed [74]. Therefore, in order to adequately predict the long-term behavior of 
biodegradable metals such as Mg and Mg alloys, an in vitro assessment must be supported by evaluating the 
degree of biocorrosion that takes place under complementary in vivo conditions. 
As with many other metals, the physico-chemical properties of Mg can be adjusted by introducing other 
elements into the alloy [75]. Changes in the chemical composition as a result of the addition of ligands 
combined with a selected processing methodology potentially improve the mechanical and corrosion behavior 
of the material, resulting in the resulting microstructure of the alloy. It has been reported that rare earth metals 
such as Gadolinium added to the alloy in small quantities have the deepest effect on the corrosion sensitivity 
of Mg alloys [25]. 
The above results clearly support the viability of Mg-based biomaterials as biocompatible, fully degradable, 
lightweight and potentially osteo-inductive materials. However, in order to truly facilitate the clinical 
application of Mg-based bioabsorbable devices, more extensive in vitro and in vivo studies are required to 
precisely verify the safety of such devices [25]. 
Also, some Fe and Fe based alloys are biodegradable. A patent has been recently registered on biodegradable 
FeMn alloys [76]. The present invention is a method for producing a permeable tubular metal alloy stent 
inserted into the container and then expanded to a certain extent to maintain the flow in the container as 
required; - Production using 3D printer, - Using 200-400 W laser source during production, - Spreading alloy 
forming powders on the tray in the production pool. 
4. Surface modifications  
The field of implantology is constantly evolving as more is learned about the specific biological 
relationships of the implant and the environment. Important factors in terms of surface engineering are 
the effect of surface chemistry, topography at micro and nanometer level, physicochemical effects and 
biochemical mediated cell differentiation, inevitable bacterial colonization of biological implants, 
biological dimensions and histology of environmental structures. Suitable surface modification 
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techniques not only maintain the desired volume properties of biomedical materials, but also improve the 
specific surface properties required by different clinical applications [77,78]. 
The focus in the following paragraph is focused on the surfaces of implant materials reserved for hard 
tissue replacements. Surface modification techniques will be discussed topographically and chemically. 
Bioactive surface modifications and physicochemical parameters such as crystallinity and wettability 
will be studied, along with existing trends to optimize topography at the nanometer level, starting with 
surface grooves at the micrometer level. 
4.1. Surface corrugation  
The effect of surface roughness on osseointegration rate and biomechanical fixation of hard tissue 
implants has been identified as a key factor. Essentially, micron-level surface topographies have been 
reported as important and various surface modification techniques have been developed that operate at 
this length scale. In particular, observation of faster and increased bone contact with micron-scale rough 
surfaces produced by scraping and subsequent acid etching stimulated considerable activities. This 
observation also leads to the conclusion that hard tissue implants based on alloys, mainly titanium, are 
not only fully bio-inert or biocompatible, but also appropriate surface conditioning may result in protein 
adsorption, cellular activity or tissue response. higher level of osseointegration. Various studies have 
shown that morphological features at the micro level control the rate and quality of new tissue formation 
at the interface [79-80]. Kieswetter et al. It suggests that the complement of autocrine and paracrine 
factors produced by cells at the bone-implant interface can be guided by changing the implant surface 
roughness, as reported by the effect of surface roughness on titanium to influence the production of local 
factors involved in bone formation by osteoblasts. and directly affect the type of interface that occurs in 
the implant site [81]. 
Numberless other investigations resulted in the ﬁnding that an optimal roughness for hard tissue 
implants is in the range of 1–10 lm. It was concluded that this range of roughness shows the ability to 
maximize the interlocking between mineralized bone and the surface of the implant [82]. Be- sides 
the experimental driven results from in vitro and in vivo investigations, theoretical calculations 
suggested  that  the  ideal  surface  structure  should  consist  of  hemispherical  pits  of  approximately 
1.5 lm in depth and 4 lm in diameter [83] that could be supported by numerous in vivo studies 
on implant topography effects [84]. 
In order to obtain well-accepted and integrated implants, the implants must be optimally mechanically 
locked into the host tissue. Not only the geometric requirements and stress distribution factors of the host 
tissue direct the topographic demands on the implant surface, but also the thought that the bone adapts to 
the mechanical loading of osteocytes acting as mechanosensors [85]. 
Various methods are used to create and construct such microstructural surface properties to meet the 
demands for increased bone implant contact formation. These methods include blasting, etching, 
anodization and plasma spraying. 
In 2019, the BIMAS-RC research group published three articles on biomedical materials. In the first they 
published a paper on “biomedical porous TiNbZrTa alloys” [86]. In this article, they produced the alloys by 
the gap holding method using an ammonium hydrogen carbonate spacer. The pore size distribution, porosity 
ratio and mechanical properties of the porous alloys obtained were investigated. Sintered porous TiNbZrTa 
alloys have been found to have suitable mechanical properties (elastic modulus: 36-38 GPa, transverse tensile 
strength: 154-281 MPa) for hard tissue implants. In the second article [87], “The effect of Zr addition on the 
corrosion behavior of biomedical PIM Ti-16Nb alloys in SBF”. They first prepared the alloys with the PIM 
technique and then carried out electrochemical corrosion tests using simulated body fluid using 
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electrochemical impedance spectroscopy and polarization curve analysis. The addition of Zr has been 
observed to be effective in increasing the corrosion resistance of the Ti16Nb alloy. 
Finally, they published an article on "New HA / graphene oxide / collagen bioactive composite coating with 
electrodeposition on Ti16Nb alloy" [88]. In this article, a new implant coating material, including grapheme 
oxide (GO) and collegen (COL) and hydroxyapatite (HA), was manufactured with the aid of tannic acid by 
electro-precipitation (Fig. 7). The surface of the Ti16Nb alloy was subjected to anodic oxidation and then HA-
GO coating was applied to the Ti16Nb surface by the cathodic method (Figure 8). Then, COL was left on the 
surface of the HA-GO coating by biomimetic method. HA, HA-GO, HA-GO-COL coatings on the surface of 
the Ti16Nb alloy have increased the corrosion resistance by creating a barrier layer on the surface. For HA-
GO-COL coating, the highest corrosion resistance is achieved due to the compactness and homogeneity of the 
coating structure (Fig. 9). The hardness and elastic modulus of the coatings were measured by the 
nanoindentation test, and the addition of GO and collagen to the HA coating caused an increase in strength. 
Adding GO to the HA coating reduces the viability of 3 T3 fibroblast cells, while adding collagen to the HA-
GO coating increased cell adhesion and viability. 
 
Figure 7. FESEM images of TiO2 NTs formed on the pretreated Ti16Nb alloy surface [A) 50.000x, B) 
200.000x] and microstructures of HA [C) 20,000x, D) 40,000x], HA-GO [E) 20,000x, F) 40,000x], HA-GO-
COL [G) 20,000x, H) 40,000x] coatings [88] 
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Figure 8. OCP curves of a. uncoated Ti16Nb alloy, b. HA, c. HA-GO, d. HA-GO-COL coatings in SBF (A), 
Potentiodynamic polarization curves of a. uncoated Ti16Nb alloy, b. HA, c. HA-GO, d. HA-GO-COL 
coatings in SBF (B) [88] 
 
Figure 9. Surface spectroscopy analysis of uncoated Ti16Nb alloy (A) and HA (B), HA-GO (C), HA-GO-
COL (D) coatings [88]. 
4.2. Surface topographies  
In the previous paragraph, techniques to change the surface topography on a micron scale are introduced. 
These surfaces often show random topographies with surface structures ranging from nanometers to 
millimeters. Zinger et al. Showed that the combination of surface modeling techniques with the next 
blasting and etching at the sub-micrometer level leads to surface roughness with combined micrometer 
and nanometer structures and therefore shows improved osteoblast activity [89]. It has been found from 
such studies that in vitro cell attachment and in vivo bone implant interface can be affected by both 
nano-scale and micro-scale parameters of topography, in which osteoblasts exhibit an improved bond on 
submicron-scale structures [90]. The role of surface roughness on both length scales at the micron or 
nanometer level requires that molecular interactions with the surface occur and, as a direct consequence, 
the cell adhesion phenomenon and local biomechanical properties of the built-in interface are directly 
affected by this length scale. Modifications of nano scale surfaces will affect the chemical reactivity of a 
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biomedical material, thereby affecting the ionic or biomolecular interactions of the surface with the host 
tissue. Such changes in surface properties modified by nano-scale modifications can alter wetting 
properties, lead to a different protein adsorption, or have an impact on the mineralization of de novo 
bone formation. The importance of topography on the nanography scale is emphasized, where an 
interpretation of the sensitive reaction to nanotopography occurs because there are minor differences in 
chemistry between one part of the topography and the other. The opposite approach is that there is a 
small difference in topography, even with small local differences in chemistry with techniques such as 
nanoprinting [91]. 
Until now, there is no precise information about the impact of such properties on the biological 
environment due to the absence of standardized surfaces with high controllable lateral resolution and 
nano-scale repetitive topography. Increased availability of a well understood and standardized surface 
structures below 100 nm will help to understand interactions between specific proteins and cells.  
In recent years, reports have been published on the special adjustment of surface properties at the 
nanometer level to investigate possible effects of surface structures in the region below 100 nm. The 
most promising approaches and the surface chemistries below will be discussed for reproducing the 
surface roughness in the desired structural sub-100 nm region with reproducibly sufficient lateral 
resolution at the nanometer scale as well as comparable surface chemistry. 
 
4.3. Chemical modification  
Biological tissue mainly interacts with the outermost atomic layers of an implant. Although secondary 
and other byproduct reactions occur, the primary interaction site is usually defined by the first atomic 
layers. Various efforts are therefore made to alter the surface of existing biomaterials to achieve desired 
biological responses [78]. In addition to the morphological modifications of the surface roughness of 
biomedical implant materials, various chemical modifications of the implant surfaces have been explored 
to achieve an optimized tissue interaction. The ideal rigid implant should provide a desired feature in any 
case, regardless of a surface that will induce osseointegration, the implantation site, the amount of bone, 
or bone quality. Therefore, physicochemical treatments are designed to directly cause surface 
interactions with the chemical nature of bone to increase and affect de novo bone formation. In principle, 
physicochemical approaches are either based on control of surface composition, surface free energy, 
wettability or electrical charges. These treatments can transform a commonly bioinert surface of an 
implant material, such as metals, into a bioactive character. 
5. Future perspective  
Surface modification of biomaterials is a broad topic that is considered in a wide range to improve implant 
performance and service life in a human body. Stainless steel, titanium, magnesium and chrome-cobalt are the 
leading implant materials in orthopedic applications. The in-depth sophisticated analysis of the published 
work on surface modification of biomaterials emphasizes that the surface modification process increases 
biocompatibility, chemical laziness, lubricity, sterility, asepsis, thrombogenicity and hydrophilicity of the 
biomaterial. Besides, it also improves superior mechanical properties. corrosion resistance, surface hardness, 
Young's modulus and wear resistance. Surface engineering with the non-traditional processing of biomaterials 
is the modernist method for the synthesis of biomaterials. With the EDM process, the surface modification 
path, the composition of the tool electrodes and the intelligent selection of machining parameters ensure the 
accumulation of minerals compatible with the human body environment, open porous structure and metallic 
residues. The combined selection of EDM process parameters improves key component properties. In 
addition, the method can develop replacement bone close to natural bone architecture at all scales and plays an 
important role in biological systems [4]. 
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From the first appearance of the 1980s to the present, PIII & D has become a popular physical technique 
suitable for surface modification of various materials. PIII & D can offer versatile processing capabilities to 
adapt the surface properties of many biomaterials by adding numerous different types of elements and 
functional groups to the materials. This study reviewed the improvement of the mechanical and bio-logical 
properties of biomaterials (Ti, Ti alloys and biopolymers) and recent progress with the PIII & D method in 
China. 
Besides composition and physical and chemical properties, the nano and microstructure of the surfaces have 
been identified as an important factor affecting a number of cellular responses such as cell morphology, 
adhesion and differentiation. However, the creation of versatile nano- or microstructures cannot be 
accomplished only with PIII & D technology. Combination of PIII & D with other manufacturing methods 
may be required to ensure optimum performance of biomedical implants and to be compatible with the 
specific requirements of biological molecules. In addition, interdisciplinary approaches will be critical for the 
design of biomaterial surfaces. Ultimately, advances in emerging biomedical applications with fully controlled 
physical, chemical and biological properties remain a major opportunity for future research [29]. 
It is well known that corrosion fatigue impairs the performance of biomedical metallic alloys, and 
these components are still responsible for most disastrous failures despite the evolution of both 
material quality and design over the years. Therefore, it can be expected that the development of 
new materials and the development of existing materials will result from this issue. Indeed, there is 
a lot of information about the isolated aspects of this problem, namely studies on the corrosion or 
fatigue of metallic biomaterials. Many authors have reported the combined action of the corrosion 
and fatigue of biomedical alloys in physiological solutions and faced the difficulty of 
understanding the synergy between them. However, the cumulative fatigue design is very 
noticeable, while fatigue crack propagation is virtually unexplored. Therefore, there is a strong 
need to investigate the crack growth behavior of metallic biomaterials in corrosive physiological 
environments, which are made up of not only saline types but also proteins and enzymes. While the 
studies linking the corrosion fatigue crack growth mechanisms of biomedical alloys with 
microstructural features such as grain size, crystal phase composition and distri bution are very 
few, experimental studies including different heat treatments and mechanical processing operations 
are not found in the literature. everything.  
Reliable estimation of the fatigue life of metallic biomaterials will only be possible with the development of 
precise models based on extensive experimental data. As can be understood from the literature examined in 
this study, this research area has the potential to expand to all typical metallic materials used for biomedical 
applications. 
The same shortage of systematic research occurs through methods of preventing and reducing 
corrosion fatigue failure. Even for traditional techniques such as sandblasting and hard thin 
coatings, corrosion fatigue studies are inadequate. This deficiency is more evi dent with the most 
up-to-date methods that produce UFG or surface nanocrystalline materials. More than an 
efficient research area, corrosion fatigue of biomedical metallic materials is a phenomenon that 
requires full understanding and prevention of important technological developments [30].  
The demand for safe and effective materials in biomedical engineering is greatly increased due to 
the annual increase in the world population, the increasing number of the elderly and the high 
functional demands of young people. The basic condition for a biomaterial is that the material 
and the surrounding physiological environment must coexist without having an undesirable effect 
on each other. Since the surface is an interface where biomaterials meet and interact with t he 
biological medium (i.e. bone, soft tissue, blood), surface properties are the main factors that 
ultimately determine the rejection or acceptance of a biomaterial in the body. Biological events 
that regulate host responses to materials such as protein ad sorption and cell adhesion occur at the 
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biomaterial-tissue interface and are modulated by the physicochemical properties of the material 
[6]. 
Many studies have been conducted on biomaterials and implants so far and these studies are still 
ongoing. In addition to the work carried out, additional studies may be proposed on the following 
special topics: 
a) Recently a lot of metallic materials (Fe, Mg, Ni and Co-based alloys as well as stainless steel) 
used as biomaterials and implants in the body. However, some more research need to be done 
about the other metallic materials such as Zr, Nb, Ru, Ag, Ta, Au, Al, Zn, Sn etc for the sake of 
biocompatibility, toxicity, allergenic and corrosion resistance.  
b) For hard tissue replacement, titanium and its alloys are widely used owing to their high 
corrosion resistance, low density, good biocompatibility, comparatively low elastic modulus, and 
high strength. Up to now, many researchers have done about the Ti -based biomaterials and 
implants. Nevertheless, to replace the conventional Ti6Al4V alloys, some more Ti -based implant 
alloys can be developed adding Zr, Ta, Sn, Hf, Re, Ag etc into Ti -Nb based alloys to eliminate 
the long-term ignition and carcinogenic effects due to release of toxic elements ions.   
c) Iron is a metal suitable for the manufacture of a biodegradable stent. However, implantation of 
some iron stents has shown that the stents are completely corroded in recorded time, and 
therefore the faster rate of deterioration for iron is of interest, and further investigation is needed 
for the degradation procedure.  
d) Pure Mg and Fe are not used directly in stent production due to their low mechanical, 
reliability and bio-reactivity properties. However, some elements can be added to Mg and Fe to 
produce biodegradable stents. For example, “Zn, Y, Ca, Mn and Ag” elements are added to Mg 
and “Co, Al, W, Sn, B, C, S” elements are added to Fe to produce better stents.  
e) Non-metal implants and biomaterials can be studied; such as polymeric materials (polyacetal, 
polysulfone and polycarbonate) can be used in the applications of heart/lung assist devices and 
hard tissue replacements. Also ceramic implants (aluminum oxide, hydroxyapatite, calcium 
phosphates and carbon) and composites (carbon-carbon, ceramic polymer, epoxy-glass, epoxy-
carbon and epoxy-aramide) can also be attractive for the implant applications in the body.  
f) The elastic modulus of Ti and its alloys is much higher than the bone and damages the bone . 
Therefore, porous alloys are prepared and matched with the mechanical properties of the bone.  
g) Modification of the Ti alloy surface can provide additional work on the ability to form apatite 
and increase corrosion resistance.  
h) Bioactive coating studies can be performed to increase the corrosion resistance and 
biofunctional properties of titanium alloys. For this purpose, HA, HA -GO and HA-GO-COL 
coatings can be applied to Titanium alloy surface by pre -treatment and post-anodization 
electroaccumulation method. 
i) Metallic biodegradable stents were produced in the first generation by casting, forging, 
machining and thermomechanical methods. Then, powder metallurgy and electro -forming method 
were used for the production of second generation stents. New modern methods such as 3D 
printing can be used in manufacturing methods of implants.  
6. Conclusions 
Recent developments of metallic implants for biomedical applications 
The biomedical implant is simply defined as an artificial organ that is used to restore the functionality of a 
damaged natural organ or tissue of the body. In other words, it is expected to perform the functions of natural 
organs or tissues without adverse effects on other parts of the body. This requires that various requirements 
are met by the material used for artificial organs or artificial organ construction before being considered for 
application. The main requirement of artificial organ or tissue replacement is that it should act as a functional 
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replacement for the original body part. Additional requirements include Biocompatibility or Biodegradability 
of the material used in the artificial organ to accommodate the surrounding tissue without any immune 
rejection response or inflammatory reaction. The following conclusions can be drawn from this study: 
a) A biomaterial must meet the suitable mechanical properties; such as a low elastic modulus combined with 
high strength to extend the service life of the implant and to prevent loosening. Also, it has to be 
biocompatible, high abrasion and corrosion resistance, osseointegration, non-toxic and long fatigue life.   
b) The materials that are used to build biomedical devices (orthopedic, dental, bone cements, etc.) can be 
classified into metallic materials, ceramics, polymers, and composites. Metallic materials in these four 
categories are widely used due to their high strength, toughness and good biocompatibility, despite some 
deficiencies such as the release of metallic ions and wear residues. 
c) Biodegradable metals, such as magnesium, hold great promise in applications that support tissue regeneration 
and healing, particularly where a load- bearing function is required, and also iron based alloys can be used as 
biodegradable metals within the body.  
d) The field of implantology is constantly evolving, as more is learned about specific biological interactions 
with and around the implant. Important factors for surface engineering include surface chemistry, micro- 
and nanometer-level topography, physicochemical effects and biological factors. 
e) There have been many studies on biomaterials and implants so far and these studies are still 
ongoing. In addition to the studies carried out, additional studies may be proposed on some more 
research need to be done about the other metallic materials, to replace the conve ntional Ti6Al4V 
alloys, some more Ti-based implant alloys can be developed, further investigation is needed for 
the degradation procedure in metallic implants.  
f) Some more porous alloys are prepared and matched with the mechanical properties of the bone 
and modification of the Ti alloy surface can provide additional work on the ability to form 
apatite and increase corrosion resistance.  
g) Metallic biodegradable stents were produced in the first generation by casting, forging, 
machining and thermomechanical methods. Then, powder metallurgy and electro -forming method 
were used for the production of second generation stents. New modern methods such as 3D 
printing can be used in manufacturing methods of implants.  
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